These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18238944)

  • 21. Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease.
    Lepor NE; Gross SB; Daley WL; Samuels BA; Rizzo MJ; Luko SP; Hickey A; Buchbinder NA; Naqvi TZ
    Am J Cardiol; 2000 Jul; 86(1):107-10. PubMed ID: 10867106
    [No Abstract]   [Full Text] [Related]  

  • 22. [Anorectics and pulmonary hypertension].
    Bíbová J; Hampl V
    Cas Lek Cesk; 2000 Feb; 139(3):67-70. PubMed ID: 10838744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary hypertension, anorexigens and 5-HT: pharmacological synergism in action?
    MacLean MR
    Trends Pharmacol Sci; 1999 Dec; 20(12):490-5. PubMed ID: 10603491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pulmonary hypertension and heart valve diseases induced by fenfluramine? Hypothesis or certitude? Myth or reality?].
    Godeau P; Cherin P; Tellier P
    Rev Med Interne; 1998 Oct; 19(10):700-3. PubMed ID: 9827440
    [No Abstract]   [Full Text] [Related]  

  • 25. The age-adjusted mortality rate from primary pulmonary hypertension, in age range 20 to 54 years, did not increase during the years of peak "phen/fen" use.
    Rothman RB
    Chest; 2000 Nov; 118(5):1516-7. PubMed ID: 11083718
    [No Abstract]   [Full Text] [Related]  

  • 26. Death from irreversible pulmonary hypertension associated with short-term use of fenfluramine and phentermine.
    Dillon KA; Putnam KG; Avorn JL
    JAMA; 1997 Oct 22-29; 278(16):1320. PubMed ID: 9343461
    [No Abstract]   [Full Text] [Related]  

  • 27. Fatal pulmonary hypertension associated with short-term use of fenfluramine and phentermine.
    Mark EJ; Patalas ED; Chang HT; Evans RJ; Kessler SC
    N Engl J Med; 1997 Aug; 337(9):602-6. PubMed ID: 9271482
    [No Abstract]   [Full Text] [Related]  

  • 28. 5-HT2C receptor modulation and the treatment of obesity.
    Bickerdike MJ; Vickers SP; Dourish CT
    Diabetes Obes Metab; 1999 Jul; 1(4):207-14. PubMed ID: 11228755
    [No Abstract]   [Full Text] [Related]  

  • 29. Appetite suppressants and pulmonary hypertension: a long-term risk.
    Prescrire Int; 2006 Oct; 15(85):183. PubMed ID: 17131516
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pulmonary hypertension following use of appetite depressants?].
    Homann G
    Med Klin; 1974 Feb; 69(5):211. PubMed ID: 4819931
    [No Abstract]   [Full Text] [Related]  

  • 31. Valvular heart disease associated with fenfluramine-phentermine.
    Spitzer WO
    N Engl J Med; 1997 Dec; 337(24):1774-5; author reply 1775-6. PubMed ID: 9411251
    [No Abstract]   [Full Text] [Related]  

  • 32. Obesity and the diet pill dilemma.
    Healy BP
    J Womens Health; 1997 Aug; 6(4):391-2. PubMed ID: 9279828
    [No Abstract]   [Full Text] [Related]  

  • 33. Aminorex to Fen/Phen: an epidemic foretold.
    Tellier P
    Circulation; 1999 Dec; 100(25):e146; author reply e147. PubMed ID: 10604912
    [No Abstract]   [Full Text] [Related]  

  • 34. Diet pills redux.
    Curfman GD
    N Engl J Med; 1997 Aug; 337(9):629-30. PubMed ID: 9271487
    [No Abstract]   [Full Text] [Related]  

  • 35. Pulmonary arterial hypertension associated with fenfluramine exposure: report of 109 cases.
    Souza R; Humbert M; Sztrymf B; Jaïs X; Yaïci A; Le Pavec J; Parent F; Hervé P; Soubrier F; Sitbon O; Simonneau G
    Eur Respir J; 2008 Feb; 31(2):343-8. PubMed ID: 17959632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further cases of valvular heart disease associated with fenfluramine-phentermine.
    Graham DJ; Green L
    N Engl J Med; 1997 Aug; 337(9):635. PubMed ID: 9280830
    [No Abstract]   [Full Text] [Related]  

  • 37. Weighing benefits and risks of drug to treat obesity.
    Sukkari SR
    CMAJ; 1997 Mar; 156(6):768-9. PubMed ID: 9084379
    [No Abstract]   [Full Text] [Related]  

  • 38. [Appetite depressant drugs and the risk of primary pulmonary hypertension].
    Olschewski H
    Pneumologie; 1997 Jun; 51(6):575-6. PubMed ID: 9333790
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary pulmonary hypertension and long-term use of appetite suppressants.
    Sztuke-Fournier A
    CMAJ; 1997 Jan; 156(1):89-90, 93-4. PubMed ID: 9006574
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of combinations of drugs for treatment of obesity: body weight and echocardiographic status.
    Whigham LD; Dhurandhar NV; Rahko PS; Atkinson RL
    Int J Obes (Lond); 2007 May; 31(5):850-7. PubMed ID: 17146452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.